Varian Medical (NYSE:VAR) today posted fiscal first-quarter results today that missed the consensus forecast on Wall Street by a penny, despite a swing to black ink for the period. The Palo Alto, Calif.-based company reported profits of $103.2 million, or $1.12 per share, on sales of $741.0 million for the three months ended Dec. 28, 2018. […]
Varian wins US tariff exclusion for Chinese-produced Halcyon systems
Varian Medical (NYSE:VAR) said today that the U.S. Trade Representative granted it a tariff exemption for its Halcyon radiotherapy system, which would normally be subject to Section 301 tariffs due to it being manufactured in China. The Palo Alto, Calif.-based company said that the exception will have a less than $1 million impact on its financial results […]
Varian receives China NMPA approval for cancer treatment system
Varian has received approval from China’s National Medical Product Administration for its Halcyon system to treat cancer. The Halcyon system is designed to treat cancer patients with radiotherapy to treat lung, prostate, breast, head & neck and other forms of cancer. The system has a human-centered and user-friendly design to improve clinical workflow, accelerate installation timeframes, expedite […]
Varian shares rise on Q4 sales beat
Shares in Varian Medical (NYSE:VAR) have risen today after the company posted fourth quarter results that beat The Street’s sales expectations, but narrowly missed earnings per share consensus. The Palo Alto, Calif.-based company posted profits of $116.8 million, or $1.26 per share, on sales of $801.6 million for the three months ended September 28, seeing the […]
ASTRO 2018 Roundup: Fujifilm enters US CT market with FCT Embrace
Fujifilm (TSE:4901) said this week it launched the FCT Embrace 85cm wide bore computed tomography imaging unit, touting it as the world’s first such device to hit the market. The system launch marks the company’s first foray into the CT field, FujiFilm said. The release was announced at the American Society for Radiation Oncology annual meeting […]
Abbott promotes Ford to COO | Personnel Moves – October 15, 2018
Abbott (NYSE:ABT) said today that it promoted the head of its medical device division, the healthcare giant’s largest segment, to be its new operations chief. In naming former medical devices VP Robert Ford as COO, Abbott said Ford oversaw the integration of St. Jude Medical and was instrumental in the debut of Abbott’s FreeStyle Libre […]
Varian acquires cloud-based oncology software dev Noona Healthcare
Varian Medical (NYSE:VAR) said today it acquired cloud-based, oncology-focused software developer Noona Healthcare for an undisclosed amount. Palo Alto, Calif.-based Varian said that Noona developed a cloud-based mobile service intended to capture cancer patient-reported outcomes. The system allows clinics to capture PROs and communicate with patients, the company added. “PROs represent a growing and significant metric […]
Varian Medical acquires radiation therapy patient management system dev HumediQ
Varian Medical (NYSE:VAR) said today it acquired privately-held HumediQ, which develops the Identify automated patient identification, positioning and management system for radiation therapy, for an undisclosed amount. Palo Alto, Calif.-based Varian said the acquisition was made to expand its motion-management portfolio as part of its “long-term growth and value creation strategy.” “Varian is focused on enabling […]
Varian Medical shares rise on Street-beating Q3
Shares in Varian Medical (NYSE:VAR) have risen in after-hours trading today after the medical device maker beat expectations on Wall Street with its third quarter fiscal year 2018 earnings results. The Palo Alto, Calif.-based company posted profits of $72.5 million, or 79¢ per share, on sales of $709.1 million for the three months ended June 29, […]
Sirtex accepts CDH acquisition offer, moves away from Varian
In the ongoing back-and-forth to acquire Sirtex Medical (ASX:SRX), it seems that Varian Medical‘s (NYSE:VAR) $1.2 billion bid just wasn’t enough. Varian said today that it heard from Sirtex that the company’s board couldn’t turn down the $1.41 billion unsolicited offer from China’s CDH Investments. The bid from CDH Investments came in at a 20% premium on Varian’s […]
Varian stands on $1.28B offer for Sirtex
Varian Medical (NYSE:VAR) said today that it stands behind its initial $1.28 billion bid to acquire Sirtex Medical (ASX:SRX) in the wake of a $1.41 billion counter offer from China’s CDH Investments. The unsolicited bid from CDH Investments came in at a 20% premium on Varian’s A$28-per-share offer, prompting Sirtex to reconsider a merger that already has approval from U.S. antitrust […]
- 1
- 2
- 3
- …
- 14
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube